Prosight Management LP 13D and 13G filings for ADC Therapeutics SA:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-13 08:58 am Sale |
2024-09-30 | 13G | ADC Therapeutics SA ADCT |
Prosight Management LP | 9,617,531 9.950% |
-9,486 (-0.10%) |
Filing |
| 2024-11-13 08:30 am Purchase |
2024-09-30 | 13G | ADC Therapeutics SA ADCT |
Prosight Management LP | 9,627,017 9.960% |
3,155,217 (+48.75%) |
Filing |
| 2024-02-13 09:47 am Purchase |
2023-12-31 | 13G | ADC Therapeutics SA ADCT |
Prosight Management LP | 6,471,800 8.000% |
2,167,282 (+50.35%) |
Filing |
| 2023-04-14 5:45 pm Purchase |
2023-04-06 | 13G | ADC Therapeutics SA ADCT |
Prosight Management LP | 4,304,518 5.300% |
4,304,518 (New Position) |
Filing |